Dr. Kumar on Immunotherapy Combinations in RCC
February 10th 2023Rohit Kumar, MD, discusses the benefits of combining immunotherapy agents with each other or with TKIs in patients with renal cell carcinoma and the unmet needs that remain for patients with RCC who do not respond to immunotherapy.
Read More